← Leaderboards
Irene Cal Y Mayor-Turnbull
Icahn School Of Medicine At Mount Sinai
$1,335,385
Attributed
$1,335,385
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $253.5K · FY2016–24$500K$375K$250K$125K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,335,385 · 3
By mechanism
K01$701,135 · 1
R21$464,750 · 1
R03$169,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Willem Mulder$11,953,843
- Michael Rendl$16,676,175
- Carlos Pãrez-Medina$1,324,529
- Clifford J Rosen$37,701,781
- Kristen Whitney$232,470
Others in their field
Top investigators on “Cell Type”
- Jeffrey P Krischer · University Of South Florida$205,371,920
- David Heimbrook · Leidos Biomedical Research, Inc.$202,908,151
- Barton F Haynes · Duke University$148,512,052
- John M Lachin · George Washington University$136,828,043
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- Hongkui Zeng · Allen Institute$115,383,238
Research focus
Cell TypeCardiacMyocardiumCellsMyocardialTissue EngineeringCardiac MyocytesInduced Pluripotent Stem CellNovel TherapeuticsAnimal ModelIn Vitro ModelIn VitroPublicationsHeart FunctionDevelopment PlansHuman EngineeringBiomedical EngineeringCareer Development3-DimensionalCardiac Tissue EngineeringEngineeringEnvironmentBioinformaticsResearch Personnel
Grant awards (9)
Novel bioengineering models to dissect cardiac cell-cell defects in arrhythmogenic cardiomyopathy$253,500
R21 · FY2024 · HL · contact PI
Novel bioengineering models to dissect cardiac cell-cell defects in arrhythmogenic cardiomyopathy$211,250
R21 · FY2023 · HL · contact PI
Defining the role of non-myocytes to achieve biologically relevant engineered myocardial tissues$84,750
R03 · FY2021 · HL · contact PI
Harnessing the Benefits of Adult Stem Cell Exosomes for Enhancing Cardiac Contractile Function$140,227
K01 · FY2020 · HL · contact PI
Defining the role of non-myocytes to achieve biologically relevant engineered myocardial tissues$84,750
R03 · FY2020 · HL · contact PI
Harnessing the Benefits of Adult Stem Cell Exosomes for Enhancing Cardiac Contractile Function$140,227
K01 · FY2019 · HL · contact PI
Harnessing the Benefits of Adult Stem Cell Exosomes for Enhancing Cardiac Contractile Function$140,227
K01 · FY2018 · HL · contact PI
Harnessing the Benefits of Adult Stem Cell Exosomes for Enhancing Cardiac Contractile Function$140,227
K01 · FY2017 · HL · contact PI
Harnessing the Benefits of Adult Stem Cell Exosomes for Enhancing Cardiac Contractile Function$140,227
K01 · FY2016 · HL · contact PI